AWM
TMO icon

Apollon Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Apollon Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1M Buy
32,040
+17,768
+124% +$8.53M 0.2% 98
2026
Q1 		$7.02M Buy
14,272
+93
+0.7% +$50.5K 0.11% 161
2025
Q4 		$8.22M Sell
14,179
-128
-0.9% -$72.4K 0.14% 138
2025
Q3 		$6.94M Buy
14,307
+2,154
+18% +$1M 0.12% 155
2025
Q2 		$4.93M Sell
12,153
-6,743
-36% -$2.82M 0.1% 187
2025
Q1 		$9.4M Buy
18,896
+5,997
+46% +$3.25M 0.21% 94
2024
Q4 		$6.71M Buy
12,899
+1,857
+17% +$1.02M 0.15% 120
2024
Q3 		$6.83M Buy
11,042
+423
+4% +$250K 0.19% 93
2024
Q2 		$5.87M Sell
10,619
-159
-1% -$91.1K 0.18% 105
2024
Q1 		$6.26M Buy
10,778
+973
+10% +$546K 0.2% 93
2023
Q4 		$5.2M Buy
9,805
+1,067
+12% +$516K 0.18% 104
2023
Q3 		$4.42M Sell
8,738
-434
-5% -$231K 0.22% 83
2023
Q2 		$4.79M Buy
9,172
+1,473
+19% +$795K 0.23% 92
2023
Q1 		$4.44M Sell
7,699
-728
-9% -$410K 0.27% 77
2022
Q4 		$4.64M Buy
8,427
+178
+2% +$94.3K 0.33% 62
2022
Q3 		$4.18M Buy
8,249
+19
+0.2% +$10.6K 0.34% 57
2022
Q2 		$4.47M Buy
8,230
+184
+2% +$101K 0.37% 50
2022
Q1 		$4.75M Sell
8,046
-92
-1% -$52.8K 0.34% 61
2021
Q4 		$5.43M Buy
8,138
+1,685
+26% +$1.05M 0.41% 50
2021
Q3 		$3.69M Buy
6,453
+332
+5% +$182K 0.51% 39
2021
Q2 		$3.09M Buy
6,121
+104
+2% +$49.1K 0.55% 41
2021
Q1 		$2.75M Buy
6,017
+4,477
+291% +$2.14M 0.53% 44
2020
Q4 		$717K Sell
1,540
-531
-26% -$249K 0.19% 102
2020
Q3 		$914K Buy
2,071
+1,109
+115% +$458K 0.41% 61
2020
Q2 		$348K Buy
+962
New +$322K 0.19% 68

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Apollon Wealth Management's TMO Position: Q2 2026 in Review

Apollon Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 124% in Q2 2026, buying an estimated $8.53M and bringing the position to 32,040 shares worth $16.1M. The position accounts for 0.2% of the portfolio, ranked #98.

Apollon Wealth Management first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Apollon Wealth Management held 32,040 shares of Thermo Fisher Scientific worth $16.1M as of Q2 2026.
  • Apollon Wealth Management bought 17,768 Thermo Fisher Scientific shares in Q2 2026, an estimated $8.53M.
  • Thermo Fisher Scientific made up 0.2% of Apollon Wealth Management's portfolio in Q2 2026, its #98 holding.
  • Apollon Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.